# AI in Hypertension: Evaluate the Clinical Task

Judge an AI tool by its defined decision, measurement quality, external performance, and effect on care—not by an impressive accuracy score alone.

![Infographic: AI in Hypertension: Evaluate the Clinical Task](https://urinenephrology.org/visual-reference/images/lesson-artificial-intelligence.png?v=20261003c)

## Name the clinical task precisely

Measuring BP, predicting future hypertension, finding secondary causes, and recommending treatment are different tasks. Define the user, intended population, input, and decision changed. A model trained to predict future risk cannot diagnose today’s hypertension or establish which medicine will improve outcomes.

## Check the truth behind the labels

Ask whether BP labels came from standardized cuff measurements, opportunistic clinic values, or billing codes. Poor labels reproduce poor practice. For a cuffless estimator, inspect clinically important error across the pressure range; correlation with cuff BP alone does not establish measurement accuracy.

## Test transport to a new population

Require evaluation outside development data and, when relevant, at a later time. Inspect calibration as well as discrimination, missing-data handling, and subgroup error. Example: a model can rank risk well yet systematically predict 20% risk for people whose observed risk is 10%.

## Review the actual decision pathway

Specify who receives the output, what they verify, and when they may override it. A flagged resistant-hypertension case still needs measurement, adherence, medicines, and secondary-cause review. Automation should not turn incomplete records into an unverified treatment instruction.

## Start with a bounded evaluated use

Illustrative support task: flag a missing home BP series for staff review; staff checks hospitalization, access, or device problems before contact. Measure completed follow-up and inappropriate alerts. An autonomous dose-changing system requires substantially different prospective safety and outcome evidence.

## Monitor after deployment

Assign responsibility for performance drift, incident review, access controls, and updates. Track false alerts, missed cases, workload, and unequal error across patients. A published retrospective accuracy result or regulatory status for one use does not validate every new clinical setting or indication.

## Supporting evidence

- [Transforming Hypertension Diagnosis and Management in The Era of Artificial Intelligence: A 2023 National Heart, Lung, and Blood Institute (NHLBI) Workshop Report.](https://pubmed.ncbi.nlm.nih.gov/39011653/)
- [Application of artificial intelligence in hypertension.](https://pubmed.ncbi.nlm.nih.gov/38689376/)

## Source lessons

- [artificial intelligence](https://urinenephrology.org/2025_UDPA_Lectures_Live/hypertension/artificial-intelligence.html)

Read alongside the full lessons; the findings and decisions shown here require the stated clinical context.